Explaining patients' beliefs about the necessity and harmfulness of antidepressants

Annals of Family Medicine
James E AikensMichael S Klinkman

Abstract

Patients' beliefs about antidepressants vary widely and probably influence adherence, yet little is known about what underlies such beliefs. This study's objective was to identify the demographic and clinical characteristics that account for patients' beliefs about antidepressants. Participants were 165 patients with unipolar nonpsychotic major depression from primary care and psychiatry clinics who were participating in the baseline phase of a multistaged trial of medication and psychotherapy. Before patients started antidepressants, interview and self-report measures were used to assess treatment beliefs, depression features, and comorbid conditions. Linear multivariate regression was used to identify the strongest correlates of perceived medication necessity and harmfulness after adjusting for age, sex, education, and the random effects of patients within clinical site. Perceived necessity was associated with older age (P <.001), more severe symptoms (P = .03), longer anticipated duration of symptoms (P=.001), and attribution of symptoms to chemical imbalance (P=.005). Perceived harmfulness was highest among patients who had not taken antidepressants before (P = .02), attributed their symptoms to random factors (P=.04), and ...Continue Reading

References

Nov 11, 1998·Depression and Anxiety·S M Maixner, J F Greden
Feb 8, 2000·Journal of Psychosomatic Research·R Horne
Mar 20, 2001·Archives of General Psychiatry·W KatonJ Unützer
Feb 2, 2002·The British Journal of Psychiatry : the Journal of Mental Science·S PampallonaC Munizza
Feb 9, 2002·Journal of the American Pharmaceutical Association : APhA·Dara C Bultman, Bonnie L Svarstad
May 10, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Stan KutcherVratislav Hadrava
Feb 14, 2003·The Journal of the American Board of Family Practice·Mark D SullivanJohn W Williams
May 3, 2003·Journal of Clinical Epidemiology·Vincent de GrootLex M Bouter
Jun 5, 2003·The Psychiatric Clinics of North America·Maurizio FavaDavid J Kupfer
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Oct 11, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Koen Demyttenaere
Nov 1, 2003·BMJ : British Medical Journal·Donald E Nease, James E Aikens
Apr 6, 2004·Controlled Clinical Trials·A John RushUNKNOWN STAR*D Investigators Group
Jul 9, 2004·Archives of General Psychiatry·Sandro PampallonaCarmine Munizza
Oct 7, 2004·The American Journal of Psychiatry·Thomas L SchwenkLydia Lewis
Jan 27, 2005·Annals of Family Medicine·James E AikensThomas L Schwenk
Apr 7, 2005·Psychiatric Services : a Journal of the American Psychiatric Association·Oscar Hugo BrookMarten de Haan
May 17, 2005·Journal of Affective Disorders·A John RushMadhukar H Trivedi
Jul 5, 2005·General Hospital Psychiatry·James E AikensGeorge J Eckert
Dec 13, 2005·Journal of General Internal Medicine·Jane L GivensFrances K Barg
Mar 24, 2006·The New England Journal of Medicine·A John RushUNKNOWN STAR*D Study Team
Sep 28, 2006·Pharmacy World & Science : PWS·Sarah CliffordRob Horne
Feb 7, 2007·Current Opinion in Psychiatry·Keith J PetrieDaniel A Devcich
May 23, 2007·Medical Care·M Robin DiMatteoSummer L Williams

❮ Previous
Next ❯

Citations

Mar 8, 2014·Attention Deficit and Hyperactivity Disorders·Pamela O'Callaghan
Mar 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Patrick J RaueMartha L Bruce
Apr 3, 2009·Journal of Psychiatric Practice·Diane WardenMadhukar H Trivedi
Aug 26, 2009·Journal of Child and Adolescent Psychopharmacology·Susan DosReisMary Anne Myers
Dec 4, 2012·Patient Preference and Adherence·Colleen A McHorneyXiaoquan Zhao
Sep 29, 2012·Issues in Mental Health Nursing·Jaclene A ZauszniewskiCarol M Musil
Jun 22, 2013·Research in Social & Administrative Pharmacy : RSAP·Wei Wen ChongTimothy F Chen
Oct 23, 2012·Revista de psiquiatrí́a y salud mental·Francisco AcostaBeatriz Cabrera
Feb 14, 2012·General Hospital Psychiatry·James E Aikens, Michael S Klinkman
Mar 1, 2012·The Psychiatric Clinics of North America·David L Mintz, David F Flynn
Oct 27, 2010·Applied Nursing Research : ANR·Jaclene A Zauszniewski
Jul 8, 2009·Depression and Anxiety·Diane WardenMadhukar H Trivedi
Feb 24, 2012·Journal of Affective Disorders·Nicola J Reavley, Anthony F Jorm
May 25, 2013·General Hospital Psychiatry·Greg Clarke, Bobbi Jo Yarborough
May 8, 2009·Journal of Affective Disorders·Marijn A PrinsJozien M Bensing
Feb 25, 2015·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Romina KollerAlexandra Schosser
Nov 26, 2014·Journal of General Internal Medicine·James E AikensJohn D Piette
Feb 11, 2012·Journal of Health Psychology·Manuela GlattackerCornelia Meffert
Nov 4, 2015·International Journal of Psychiatry in Medicine·James E AikensDonald E Nease
Oct 28, 2017·The Journal of Nervous and Mental Disease·Bonnie L GreenMarcela Campoli
Nov 27, 2018·Nurse Researcher·Jaclene A ZauszniewskiKayla Herbell
Feb 24, 2010·Applied Health Economics and Health Policy·Regina Rendas-BaumGene V Wallenstein
Jul 11, 2009·Expert Review of Neurotherapeutics·Maurizio PompiliDavid Lester
Aug 1, 2013·Expert Review of Neurotherapeutics·Maurizio PompiliPaolo Girardi
Dec 17, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·R HouR Peveler
Sep 14, 2019·Therapeutic Advances in Psychopharmacology·Rhona EveleighPeter Lucassen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Psychiatrica Scandinavica
Ravi Lingam, Jan Scott
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Koen Demyttenaere
The Journal of Clinical Psychiatry
Charles B Nemeroff
© 2021 Meta ULC. All rights reserved